Clinical trials
Alzheimer Disease trials in the United States with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 10 |
| 2022 | 12 |
| 2023 | 8 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 94 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute on Aging (NIA) | 9 |
| Massachusetts General Hospital | 3 |
| APRINOIA Therapeutics, LLC | 2 |
| Allyx Therapeutics | 2 |
| Banner Health | 2 |
| Bellus Health Inc. - a GSK company | 2 |
| Navidea Biopharmaceuticals | 2 |
| Oregon Health and Science University | 2 |
| Rhode Island Hospital | 2 |
| The Methodist Hospital Research Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 94 |
| Cognitive Dysfunction | 30 |
| Dementia | 27 |
| Memory Disorders | 7 |
| Parkinson Disease | 5 |
| Brain Injuries, Traumatic | 4 |
| Dementia, Vascular | 4 |
| Frontotemporal Dementia | 4 |
| Diabetes Mellitus | 3 |
| Down Syndrome | 3 |
Trials
Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.